Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 7/20 | 0.97 |
| ▸ | HTR2A | P28223 | 7/20 | 0.97 |
| ▸ | HTR1A | P08908 | 7/20 | 0.97 |
| ▸ | HTR1D | P28221 | 6/20 | 0.97 |
| ▸ | HTR1B | P28222 | 4/20 | 0.97 |
| ▸ | HTR7 | P34969 | 3/20 | 0.97 |
| ▸ | HTR2B | P41595 | 2/20 | 0.97 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.97 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.97 |
| ▸ | TSHR | P16473 | 2/20 | 0.97 |
| ▸ | HTR5A | P47898 | 2/20 | 0.97 |
| ▸ | HTR6 | P50406 | 2/20 | 0.97 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.97 |
| ▸ | HTR3B | O95264 | 1/20 | 0.97 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.97 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.97 |
| ▸ | DRD1 | P21728 | 1/20 | 0.97 |
| ▸ | HTR1E | P28566 | 1/20 | 0.97 |
| ▸ | HTR1F | P30939 | 1/20 | 0.97 |
| ▸ | DRD3 | P35462 | 1/20 | 0.97 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Serotonin SCHEMBL30057954 | 0.98 | HTR2C (1.00) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL29349412 | 0.98 | HTR2C (1.00) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL1495 | 0.98 | HTR2C (1.00) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL183226 | 0.98 | HTR2C (1.00) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL25341783 | 0.97 | HTR2C (1.00) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL8208967 | 0.97 | HTR2C (1.00) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL29781387 | 0.97 | HTR2C (1.00) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL28576451 | 0.97 | HTR2C (0.97) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL396997 | 0.97 | HTR2C (0.97) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL3091827 | 0.97 | HTR2C (0.97) | HTR2CHTR2AHTR1AHTR1DHTR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1687314-B1 | PREPARATION OF 1-AZA-2-OXA-DIBENZO [e,h] AZULENES AND THEIR USE FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS | GLAXOSMITHKLINE ZAGREB (HR) | 2008-12-24 | — | — | EP | claimed |
| EP-1684766-B1 | USE OF 3-AZA-1-OXA-DIBENZO i e,h /i AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEAS AND DISORDERS | GLAXOSMITHKLINE ZAGREB (HR) | 2007-06-27 | — | — | EP | claimed |
| CN-117752734-A | New use of liver and kidney tonifying compound traditional Chinese medicine in treatment of fibromyalgia syndrome | 安徽中医药大学第一附属医院(安徽省中医院) | 2024-03-26 | — | — | CN | disclosed |
| WO-2024040322-A1 | BIOMIMETIC PEPTIDES DERIVED FROM THE FACTOR THYMOSIN-B4, FUNCTIONALIZED WITH 5-HT AND 5-HTP*, DERMOCOSMETIC AND BIOPHARMACEUTICAL COMPOSITIONS CONTAINING THE PEPTIDES AND USES THEREOF | NANOCEUTICALS (BR) | 2024-02-29 | — | — | WO | disclosed |
| US-11896600-B2 | Composition and method of using eicosanoyl-5-hydroxytryptamide for treating neurodegenerative disorders | Vidya Herbs, Inc. (US) | 2024-02-13 | — | — | US | disclosed |
| WO-2023133159-A1 | WEARABLE APTAMER FIELD-EFFECT TRANSISTOR SENSING SYSTEM FOR NONINVASIVE CORTISOL MONITORING AND WEARABLE SYSTEM FOR STRESS SENSING | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-07-13 | — | — | WO | disclosed |
| WO-2023099589-A1 | IRAP INHIBITORS FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2023-06-08 | — | — | WO | disclosed |
| US-20230147744-A1 | METHODS TO ENRICH ENTEROENDOCRINE CELLS AND THEIR SUBTYPES IN THE CONTIGUOUS, INTESTINAL MONOLAYER SYSTEMS | UNIVERSITY OF WASHINGTON | 2023-05-11 | — | — | US | disclosed |
| US-20230098772-A1 | ADVANCED MICROBIOME THERAPEUTICS ENGINEERED TO PRODUCE SEROTONIN IN VIVO | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2023-03-30 | — | — | US | disclosed |
| EP-4126218-A1 | METHODS TO ENRICH ENTEROENDOCRINE CELLS AND THEIR SUBTYPES IN THE CONTIGUOUS, INTESTINAL MONOLAYER SYSTEMS | The University of North Carolina at Chapel Hill (US) | 2023-02-08 | — | — | EP | disclosed |
| CN-110041318-B | Dopamine D5 receptor agonist and preparation and application thereof | 中国科学院上海药物研究所 | 2022-07-29 | — | — | CN | disclosed |
| WO-2001013715-A2 | ANIMAL MODEL AND USES THEREOF | THE BABRAHAM INSTITUTE (GB) | 2001-03-01 | — | — | WO | disclosed |
| WO-2000064935-A1 | A NOVEL SEROTONIN-GATED ANION CHANNEL | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2000-11-02 | — | — | WO | disclosed |
| US-6060642-A | TRANSGENIC MICE MODELS FOR GENE FUNCTION, WHEREIN THE TRANSGENIC MICE ARE CHARACTERIZED BY HAVING ALTERED SEROTONIN 5-HT6 RECEPTOR GENE FUNCTION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-05-09 | — | — | US | disclosed |
| US-5990094-A | SEROTONIN N-ACETYLTRANSFERASE INHIBITORS WHICH CAN SERVE AS BIOLOGICAL TOOLS THAT HELP REVEAL BIOLOGICAL FUNCTIONS FOR MELATONIN AND PINEAL SEROTONIN IN VIVO; ACETYL-COA N-ACETYL TRYPTAMINE DERIVATIVES OF GIVEN STRUCTURE | THE ROCKEFELLER UNIVERSITY (US) | 1999-11-23 | — | — | US | disclosed |
| WO-1998055141-A9 | METHODS AND PRODUCTS FOR INDUCING APOPTOSIS IN NEUROENDOCRINE CELLS WITH MACROPHAGE STIMULATING PROTEIN | BRIGHAM & WOMENS HOSPITAL (US) | 1999-04-08 | — | — | WO | disclosed |
| EP-0893950-A1 | SELECTIVE TARGET CELL ACTIVATION BY EXPRESSION OF A G PROTEIN-COUPLED RECEPTOR ACTIVATED SUPERIORLY BY SYNTHETIC LIGAND | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1999-02-03 | — | — | EP | disclosed |
| WO-1998055141-A1 | METHODS AND PRODUCTS FOR INDUCING APOPTOSIS IN NEUROENDOCRINE CELLS WITH MACROPHAGE STIMULATING PROTEIN | BRIGHAM & WOMEN'S HOSPITAL, INC. (US) | 1998-12-10 | — | — | WO | disclosed |
| WO-1997035478-A1 | SELECTIVE TARGET CELL ACTIVATION BY EXPRESSION OF A G PROTEIN-COUPLED RECEPTOR ACTIVATED SUPERIORLY BY SYNTHETIC LIGAND | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-10-02 | — | — | WO | disclosed |
| EP-0165800-A1 | Support material for immobilisation of ligands | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1985-12-27 | — | — | EP | disclosed |